AtriCure, Inc. (ATRC) is a Healthcare stock trading at $47.53 (as of 2026-08-20), with a market capitalization of $2.42B and a trailing P/E of 229.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
AtriCure, Inc. develops and sells surgical treatment systems and related disposable devices for cardiac tissue ablation and procedures involving intercostal nerves. Its product lines include radiofrequency ablation clamps and pens, cryoablation and guided coagulation systems, and implantable or surgical adjunct devices, which it supplies to medical centers in the United States and internationally.
AtriCure develops, manufactures, and sells surgical ablation devices and systems for cardiac tissue and intercostal nerves, including single-use disposable radio frequency products, to medical centers, and it makes money from selling these devices and disposables used during procedures.
Because AtriCure sells both procedure tool systems and single-use disposable radio frequency products used in cardiac procedures, its profit engine is tied to clinician and site adoption that drives repeat disposable usage, not just one-time device sales.
| US AtriClip | $0.0B |
| US Open Abl Ex Pain | $0.0B |
| US Pain Mgmt | $0.0B |
| International | $0.0B |
Business quality (Weak): Good visibility into product and geography-related revenue components, but the dataset does not specify the company’s exact official reportable segment names, and several candidate figures look like they may overlap or be rounded relative to the total.
| Price | $47.53 |
| Market Cap | $2.42B |
| P/E Ratio | 229.1 |
| EV / EBITDA | 93.3 |
| Price / Book | 4.68 |
| Price / Sales | 4.24 |
| FCF Yield | 2.2% |
| DCF Value (model) | $10.38 |
| DCF Upside vs Price | -78.2% |
| Revenue (TTM) | $534.53M |
| Net Margin | -2.1% |
| Revenue Growth (YoY) | 12.8% |
| EPS Growth (YoY) | -238.5% |
| FCF Growth (YoY) | -2.8% |
| Altman Z-Score | 9.08 (safe) |
| Piotroski F-Score | 7/9 (strong) |
| Stock P/E | 229.1 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | 961.0% |
| vs Industry | 597.0% |
| Top Institutional Holder | VANGUARD GROUP INC ($193.99M) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 4 |
| Sector | Healthcare |
| Industry | Medical Equipment |
| CEO | Michael H. Carrel |
| Employees | 1,300 |
| Country | US |
| IPO Date | 2005-08-05 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.